Primary Biliary Cholangitis: A Brief Overview
Justin S. Louie, Sirisha Grandhe, Karen Matsukuma, Christopher L. Bowlus – 4 April 2020
Liver Transplantation in an ICU Dominated by COVID‐19
Filipe S. Cardoso – 4 April 2020
The Role of Salvage Transplantation in Patients Initially Treated With Open Versus Minimally Invasive Liver Surgery: An Intention‐to‐Treat Analysis
Giovanni B. Levi Sandri, Quirino Lai, Matteo Ravaioli, Stefano Di Sandro, Emanuele Balzano, Duilio Pagano, Paolo Magistri, Fabrizio Di Benedetto, Massimo Rossi, Salvatore Gruttadauria, Paolo De Simone, Giuseppe M.
Living Donor Liver Transplantation for Imatinib‐Resistant Gastrointestinal Stromal Tumor Liver Metastases: A New Therapeutic Option in Transplant Oncology
Carlos Benítez, Martin Inzunza, Sergio Riveros, Violeta Rivas, Marcelo Garrido, Martin Dib, Francisco Barrera, Juan P. Arab, Javiera Torres, Luis I. Cortinez, Eduardo Briceño, Juan F. Guerra, Eduardo Fernandes, Jorge A. Martínez – 4 April 2020
Primary Sclerosing Cholangitis: Epidemiology, Genetics, Diagnosis, and Current Management
Eric Gochanour, Channa Jayasekera, Kris Kowdley – 4 April 2020
Inherited Cholestatic Diseases in the Era of Personalized Medicine
Alyssa Goldberg, Cara L. Mack – 4 April 2020
Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B
Stephane Daffis, Scott Balsitis, Jason Chamberlain, Jim Zheng, Rex Santos, William Rowe, Dhivya Ramakrishnan, Divya Pattabiraman, Sandra Spurlock, Ruth Chu, Don Kang, Michael Mish, Ricardo Ramirez, Li Li, Bei Li, Sarina Ma, Magdeleine Hung, Christian Voitenleitner, Changsuek Yon, Manasa Suresh, Stephan Menne, Paul Cote, William E. Delaney, Richard Mackman, Simon P. Fletcher – 4 April 2020
Pediatric Cholestasis: Epidemiology, Genetics, Diagnosis, and Current Management
Saul J. Karpen – 4 April 2020
Coronavirus disease 2019 and prevalence of chronic liver disease: A meta‐analysis
Alessandro Mantovani, Giorgia Beatrice, Andrea Dalbeni – 4 April 2020 – At present, there is scarce information regarding the global prevalence of chronic liver disease in individuals with coronavirus disease 2019 (COVID‐19) disease, which is becoming a global pandemic. The aim of this study was to assess the overall prevalence of chronic liver disease among patients with COVID‐19 disease by meta‐analysing data in observational studies and to investigate the relationship between liver damage and COVID‐19 disease.
Clinical characteristics of non‐ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study
Hansheng Xie, Jianming Zhao, Ningfang Lian, Su Lin, Qunfang Xie, Huichang Zhuo – 2 April 2020